Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/30749
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRevathi, S-
dc.contributor.authorGupta, Arun Kumar-
dc.contributor.authorSoni, Love Kumar-
dc.contributor.authorKavitha, S-
dc.contributor.authorWagh, R-
dc.contributor.authorKaskhedikar, S G-
dc.date.accessioned2015-03-03T11:46:28Z-
dc.date.available2015-03-03T11:46:28Z-
dc.date.issued2006-12-
dc.identifier.issn0975-0983(Online); 0376-4699(Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/30749-
dc.description2763-2769en_US
dc.description.abstractCyclooxygenase-2 inhibitors arc of current interest, because these alleviate inflammation, fever, pain, rheumatic and osteoarthritis without side effects, produced by classical NSAlDs. QSAR analysis helps in exploring molecular insight, which are responsible for drug-receptor interactions. QSAR studies have been performed on a series of some 2,3-diaryl-pyrazolo[1,5-b)pyridazine analogs as COX-2 inhibitors using substituent constant in lead structure for 2D and physicochemical properties of molecules for 3D-QSAR analysis respectively. The correlations have been established using regression analysis techniques. 2D-QSAR analysis study has revealed that the substitution of hydrophobic group in the 2,3-diaryl-pyrazolo[1,5-b)pyridazines at R2 position is favourable while substitution of bulkier group at R2 position is unfavourable for COX-2 inhibitory activity. In 3D-model, Morl4u and Mor29v are 3D-MoRSE code have been calculated by summing atom weights which have been viewed by a different angular scattering function contributed positively to COX-2 inhibitory activity. G (O..O) is a conformational dependent descriptor based on the geometry of the molecule contributed negatively to COX-2 inhibitory activity. en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.relation.ispartofseriesInt. Cl.8 C07Den_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJC-B Vol.45B(12) December 2006]en_US
dc.subject2D-QSARen_US
dc.subject3D-QSARen_US
dc.subjectCOX-2 inhibitorsen_US
dc.subject2,3-diarylpyrazolo[1,5-b)pyridazine analogsen_US
dc.subjectAustin model-1 methoden_US
dc.titleQSAR studies of 2,3-diarylpyrazolo[1,5-b]-pyridazine analogs as cyclooxygenase-2 inhibitors en_US
dc.typeArticleen_US
Appears in Collections:IJC-B Vol.45B(12) December 2006]

Files in This Item:
File Description SizeFormat 
IJCB 45B(12) 2763-2769.pdf1.33 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.